Loading…
Definium Therapeutics, Inc. is projected to rise to $63.54 by 2027, a +35% move from its current price of $47.07. DFTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $45.26 | $47.11 | $49.04 | +0.08% |
| Jul 13 | $44.55 | $47.15 | $49.90 | +0.17% |
| Jul 14 | $44.02 | $47.19 | $50.58 | +0.25% |
| Jul 15 | $43.59 | $47.23 | $51.17 | +0.33% |
| Jul 16 | $43.21 | $47.27 | $51.70 | +0.42% |
| Jul 17 | $42.88 | $47.30 | $52.19 | +0.50% |
| Jul 18 | $42.58 | $47.34 | $52.64 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.58 | $47.34 | $52.64 | +0.58% |
| Week 2 | $40.98 | $47.62 | $55.33 | +1.17% |
| Week 3 | $39.86 | $47.90 | $57.56 | +1.76% |
| Week 4 | $38.96 | $48.18 | $59.56 | +2.35% |
| Week 5 | $38.22 | $48.46 | $61.43 | +2.94% |
| Week 6 | $37.58 | $48.74 | $63.20 | +3.54% |
| Week 7 | $37.02 | $49.02 | $64.91 | +4.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Definium Therapeutics, Inc. is a clinical biopharmaceutical company focused on brain health disorders. It develops novel product candidates to treat brain health disorders, including DT120, which is in phase 3 for generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of autism spectrum disorder.
The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. is headquartered in New York, New York.
Definium Therapeutics, Inc. trades under the symbol DFTX and is currently priced at $46.55. It has a market cap of $6.18B and is ranked 1172 by market capitalization. The stock sits in the Healthcare sector with a bullish longer-term outlook according to forecast data, showing upside across multiple future years.
A major floor 70.5% below — a decisive break under it would weaken the trend.
The nearest floor, 51.4% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 38.2% above — clearing it would confirm fresh momentum.
Key DFTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DFTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $45.93 | Buy | $46.27 | Buy |
| MA 10 | $45.58 | Buy | $44.24 | Buy |
| MA 20 | $38.06 | Buy | $39.62 | Buy |
| MA 50 | $28.67 | Buy | $31.77 | Buy |
| MA 100 | $24.03 | Buy | $26.15 | Buy |
| MA 200 | $18.70 | Buy | $20.74 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 75.77 | Sell |
| Stoch RSI (14) | 0.99 | Buy |
| CCI (20) | 69.87 | Neutral |
| Williams %R (14) | -11.25 | Info |
| MACD (12,26,9) | 0.39 | Buy |
| ROC (12) | 30.10 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 88.75 | Sell |
| TRIX (15) | 2.80 | Buy |
| Awesome (5,34) | 13.92 | Buy |
| Ultimate (7,14,28) | 63.60 | Neutral |
| Momentum (10) | 2.28 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 47.06 | Buy |
| ADX (14) | 45.47 | Buy |
| ATR (14) | 1.49 | Info |
The sentiment is BULLISH, and the RSI14 is 90. The stock’s near-term moving averages show a bullish setup, with SMA50 at $25.00 and SMA200 at $17.26. Price actions indicate resistance at $46.55 and support at $20.02.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.51 | $47.07 | $70.80 | 0% | Neutral | |
| $48.38 | $63.54 | $89.48 | +35% | Bullish | |
| $46.98 | $64.42 | $95.46 | +37% | Bullish | |
| $53.18 | $75.61 | $116.52 | +61% | Bullish | |
| $53.09 | $77.99 | $124.18 | +66% | Bullish | |
| $57.03 | $86.31 | $141.39 | +83% | Bullish | |
| $71.23 | $110.87 | $186.27 | +136% | Bullish | |
| $80.99 | $129.48 | $222.56 | +175% | Bullish | |
| $93.43 | $153.25 | $268.95 | +226% | Bullish | |
| $98.93 | $166.33 | $297.59 | +253% | Bullish | |
| $137.77 | $260.05 | $503.88 | +452% | Bullish | |
| $233.49 | $518.86 | $1,126.52 | +10.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $13.51 | $47.07 | $56.43 | +0.00% |
| August 2026 | $40.57 | $48.51 | $60.00 | +3.06% |
| September 2026 | $42.02 | $50.77 | $63.80 | +4.65% |
| October 2026 | $41.51 | $50.60 | $64.45 | -0.32% |
| November 2026 | $41.70 | $51.22 | $65.96 | +1.22% |
| December 2026 | $43.99 | $54.42 | $70.80 | +6.24% |
Click any year to see its month-by-month DFTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DFTX is projected to trade between $13.51 and $70.80, averaging $47.07 — a potential gain of 0% from today's $47.07. A consolidation phase looks the most probable path here.
Definium Therapeutics, Inc.'s 2027 outlook centres on $63.54, within a $48.38 to $89.48 range. That is up +35% on the projected 2026 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2028, DFTX could reach as high as $95.46, with a base case around $64.42 and support toward $46.98 — roughly +37% from $47.07. Buyers look set to stay in control over this stretch.
Expect DFTX to range from $53.18 to $116.52 through 2029. The $75.61 average target implies a +61% move from current prices. That is up +17% on the projected 2028 average. Momentum favours further upside here.
The DFTX price prediction for 2030 points to an average of $77.99 (low $53.09, high $124.18) — a potential gain of +66% on today's $47.07. Buyers look set to stay in control over this stretch.
In 2031, DFTX is projected to trade between $57.03 and $141.39, averaging $86.31 — a potential gain of +83% from today's $47.07. That is up +11% on the projected 2030 average. Momentum favours further upside here.
Definium Therapeutics, Inc.'s 2032 outlook centres on $110.87, within a $71.23 to $186.27 range. That is up +28% on the projected 2031 average. That marks a +136% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DFTX could reach as high as $222.56, with a base case around $129.48 and support toward $80.99 — roughly +175% from $47.07. Momentum favours further upside here.
Expect DFTX to range from $93.43 to $268.95 through 2034. The $153.25 average target implies a +226% move from current prices. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DFTX price prediction for 2035 points to an average of $166.33 (low $98.93, high $297.59) — a potential gain of +253% on today's $47.07. Momentum favours further upside here.
In 2040, DFTX is projected to trade between $137.77 and $503.88, averaging $260.05 — a potential gain of +452% from today's $47.07. That is up +56% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Definium Therapeutics, Inc.'s 2050 outlook centres on $518.86, within a $233.49 to $1,126.52 range. That is up +100% on the projected 2040 average. That marks a +10.0x change versus current levels. Momentum favours further upside here.
Investing $1,000 in DFTX today (≈ 21.244954 DFTX) could be worth
$11,023.22
+$10,023.22 (+1002%) by 2050 · US Dollar
Based on the average projected DFTX price of $518.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DFTXwould be worth at today's price.
$1,000 invested in DFTX on Jul 10, 2025 (≈ 123.456784 DFTX) would be worth
$5,811.11
+$4,811.11 (+481.1%) today · 5.81× · US Dollar
Based on a DFTX entry price of $8.1 vs. today's $47.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $44.19 | $1,065.17 | +6.5% |
| 1 month ago | $23.24 | $2,025.39 | +102.5% |
| 3 months ago | $21.53 | $2,186.25 | +118.6% |
| 6 months ago | $13.88 | $3,391.21 | +239.1% |
| 1 year ago | $8.1 | $5,811.11 | +481.1% |
| All time (5.0y) ago | $54.6 | $862.09 | -13.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DFTX forecast.
Our base-case forecast reaches $94.00 around 2032.
Implied market cap at $94.00: $12.48B
The multi-year forecast shows a strong bullish path, with the 2026 average price at $46.55 (ROI 0, sentiment NEUTRAL) and rising in subsequent years. Notable annual averages include 2027 at $61.91 (ROI 33, bullish), 2028 at $62.20 (ROI 33.6, bullish), 2029 at $73.43 (ROI 57.7, bullish), 2030 at $72.82 (ROI 56.4, bullish), 2031 at $80.66 (ROI 73.3, bullish), 2032 at $105.07 (ROI 125.7, bullish), 2033 at $120.16 (ROI 158.1, bullish), 2034 at $145.52 (ROI 212.6, bullish), 2035 at $156.98 (ROI 237.2, bullish), 2040 at $241.02 (ROI 417.8, bullish), and 2050 at $471.65 (ROI 913.2, bullish). These are estimates, not guarantees, and reflect potential upside with substantial long-term growth.
Tap a question to reveal the answer.
Avg price $72.82 with ROI 56.4% and sentiment BULLISH; the range includes a minimum of $48.16 and a maximum of $119.20.
Forecasts show a bullish trajectory with rising average prices and high ROI over time (e.g., 2035 ROI 237.2%, 2040 ROI 417.8%, 2050 ROI 913.2%), but these are estimates and not guarantees.
Yes. The 2032 forecast shows an average price of $105.07 with a maximum of $182.10, indicating that the asset could exceed $100 by that year.
Low $34.81 and High $62.25.
Definium Therapeutics, Inc. Community Discussion
0Share your Definium Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.